{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/gynaecological-cancers-recognition-referral/","result":{"data":{"firstChapter":{"id":"65e105c6-5f7b-59ad-9801-824c409f981c","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 1ac8246f-1823-4d2b-af87-0553692096e0 --><h1>Gynaecological cancers - recognition and referral: Summary</h1><!-- end field 1ac8246f-1823-4d2b-af87-0553692096e0 -->","htmlStringContent":"<!-- begin item 62798cdb-acc8-47ec-9144-15692d5db506 --><!-- begin field 6706ac15-206f-4341-a381-8b0d8a3b4ff6 --><ul><li>Ovarian cancer — over 7000 new ovarian cancers are diagnosed each year in the UK. A full time GP is likely to diagnose approximately one person with ovarian cancer every 3–5 years. The 5-year survival is dependent upon the stage at diagnosis.</li><li>Refer the woman urgently if physical examination identifies ascites and/or a pelvic or abdominal mass (which is not obviously uterine fibroids).</li><li>Carry out tests in primary care if a woman (especially if 50 years or over) reports having any of the following symptoms on a persistent or frequent basis – particularly more than 12 times per month:<ul><li>Persistent abdominal distension (women often refer to this as 'bloating').</li><li>Feeling full (early satiety) and/or loss of appetite.</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency and/or frequency.</li></ul></li><li>Consider carrying out tests in primary care if a woman reports unexplained weight loss, fatigue, or changes in bowel habit.</li><li>Measure serum CA125 in primary care in women with symptoms that suggest ovarian cancer. If serum CA125 is 35 IU/ml or greater, arrange an ultrasound scan of the abdomen and pelvis.</li><li>If the ultrasound suggests ovarian cancer, refer the woman urgently for further investigation.</li><li>Endometrial cancer — around 8000 new endometrial cancers are diagnosed each year in the UK. A full time GP is likely to diagnose approximately one person with endometrial cancer every 3–5 years. The 5-year survival is close to 80%.</li><li>Refer women using a suspected cancer pathway referral (for an appointment within 2 weeks) for endometrial cancer if they are aged 55 years and over with post-menopausal bleeding (unexplained vaginal bleeding more than 12 months after menstruation has stopped because of the menopause). </li><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for endometrial cancer in women aged under 55 years with post-menopausal bleeding.</li><li>Consider a direct access ultrasound scan to assess for endometrial cancer in women aged 55 years and over with:<ul><li>Unexplained symptoms of vaginal discharge who: are presenting with these symptoms for the first time, or have thrombocytosis, or report haematuria, or</li><li>Visible haematuria, and low haemoglobin levels, or thrombocytosis, or high blood glucose levels.</li></ul></li><li>Cervical cancer — just below 3000 new cervical cancers are diagnosed each year in the UK, around three quarters of these following screening. A full time GP is likely to diagnose one person with cervical cancer approximately every 10 years. The 5-year survival is approximately 65%.<ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for women if, on examination, the appearance of their cervix is consistent with cervical cancer.</li></ul></li><li>Vulval cancer — over 1000 new vulval cancers are diagnosed each year in the UK. A full time GP is likely to diagnose approximately one person with vulval cancer during their career.<ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for vulval cancer in women with an unexplained vulval lump, ulceration, or bleeding.</li></ul></li><li>Vaginal cancer — over 250 new vaginal cancers are diagnosed each year in the UK, meaning most GPs will not encounter a woman with the disease during their career. The 5-year survival varies considerably with stage.<ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for vaginal cancer in women with an unexplained palpable mass in or at the entrance to the vagina.</li></ul></li></ul><!-- end field 6706ac15-206f-4341-a381-8b0d8a3b4ff6 --><!-- end item 62798cdb-acc8-47ec-9144-15692d5db506 -->","topic":{"id":"ee6103b8-1f49-5865-acd7-5a9d20d194e6","topicId":"e261ffa1-7f7e-430a-9e12-c985aaca7f4d","topicName":"Gynaecological cancers - recognition and referral","slug":"gynaecological-cancers-recognition-referral","aliases":[],"chapters":[{"id":"65e105c6-5f7b-59ad-9801-824c409f981c","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"e401d47d-3905-5eda-b3cd-1b4eef408bdf","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"e31afef3-1c88-506d-ad84-0a6b30b9dba1","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"278052bd-be26-5c26-84bc-2113aee7dc30","slug":"changes","fullItemName":"Changes"},{"id":"efc1c0f8-bdb1-5114-97b1-648a6a52a459","slug":"update","fullItemName":"Update"}]},{"id":"e8e62e95-f70c-5b2b-9b10-0c9c5f2e9c95","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f85ffb79-0957-5932-821c-906cec331a84","slug":"goals","fullItemName":"Goals"},{"id":"7d1d0b80-0602-5d4c-98eb-6a49f27689c0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9244c05b-86d8-5f85-b189-5479cde68eeb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b605e7ea-7a24-5403-96d0-e0fac5a89219","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"703f3f20-548e-5808-a218-c091ab3b216f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f4beaa7f-d7cd-576b-8692-c4516abd0c56","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e14ce3a1-8460-551b-a361-43faa360c514","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"47f1f404-6941-5185-bcab-0175066bad01","slug":"presentation","fullItemName":"Presentation"},{"id":"a9c43384-a7d0-51f4-8d73-6b71541884df","slug":"prevalence","fullItemName":"Prevalence"},{"id":"044108ce-710b-5ec8-a3ae-429b107039bf","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9da77476-bb29-59ac-a917-0d3da982f80f","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"8a44798e-bc7c-5377-9f3c-b743ee5a7af7","slug":"symptoms-suggestive-of-gynaecological-cancers","fullItemName":"Symptoms suggestive of gynaecological cancers"}]},{"id":"b5a02174-cd66-5e92-9819-0302058cf230","slug":"management","fullItemName":"Management","subChapters":[{"id":"415eae91-f38a-5ccc-95f0-68d5ca386095","slug":"referral-for-suspected-gynaecological-cancer","fullItemName":"Scenario: Referral for suspected gynaecological cancer"}]},{"id":"8f87e182-3ee3-55c3-b6ff-ee2773b11083","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"7030c633-3342-56a4-872a-5d01b1950d05","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"3e4a0622-59ba-59f1-a249-25f37835db8f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"598e9e20-db1b-5bd6-bad9-da74dd559795","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d01e7124-01f5-52fc-a22b-2f245daf8632","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e5593853-81b8-58eb-a621-1e437e26ef58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"06edaae5-710d-5a2f-8d9f-e20e29be3d6e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4aae08c9-f011-5561-8ca0-183457de55ec","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"ee6103b8-1f49-5865-acd7-5a9d20d194e6","topicId":"e261ffa1-7f7e-430a-9e12-c985aaca7f4d","topicName":"Gynaecological cancers - recognition and referral","slug":"gynaecological-cancers-recognition-referral","aliases":[],"topicSummary":"Ovarian cancer - Over 7,000 new ovarian cancers are diagnosed each year in the UK.","lastRevised":"Last revised in February 2021","nextPlannedReviewBy":"2025-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2025-07","nextPlannedReviewByDisplay":"July 2025","specialities":[{"id":"46239e57-7990-560a-810f-b31000558649","name":"Cancer","slug":"cancer"}],"chapters":[{"id":"65e105c6-5f7b-59ad-9801-824c409f981c","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"e401d47d-3905-5eda-b3cd-1b4eef408bdf","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"e31afef3-1c88-506d-ad84-0a6b30b9dba1","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"278052bd-be26-5c26-84bc-2113aee7dc30","slug":"changes","fullItemName":"Changes"},{"id":"efc1c0f8-bdb1-5114-97b1-648a6a52a459","slug":"update","fullItemName":"Update"}]},{"id":"e8e62e95-f70c-5b2b-9b10-0c9c5f2e9c95","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f85ffb79-0957-5932-821c-906cec331a84","slug":"goals","fullItemName":"Goals"},{"id":"7d1d0b80-0602-5d4c-98eb-6a49f27689c0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9244c05b-86d8-5f85-b189-5479cde68eeb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b605e7ea-7a24-5403-96d0-e0fac5a89219","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"703f3f20-548e-5808-a218-c091ab3b216f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f4beaa7f-d7cd-576b-8692-c4516abd0c56","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e14ce3a1-8460-551b-a361-43faa360c514","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"47f1f404-6941-5185-bcab-0175066bad01","slug":"presentation","fullItemName":"Presentation"},{"id":"a9c43384-a7d0-51f4-8d73-6b71541884df","slug":"prevalence","fullItemName":"Prevalence"},{"id":"044108ce-710b-5ec8-a3ae-429b107039bf","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9da77476-bb29-59ac-a917-0d3da982f80f","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"8a44798e-bc7c-5377-9f3c-b743ee5a7af7","slug":"symptoms-suggestive-of-gynaecological-cancers","fullItemName":"Symptoms suggestive of gynaecological cancers"}]},{"id":"b5a02174-cd66-5e92-9819-0302058cf230","slug":"management","fullItemName":"Management","subChapters":[{"id":"415eae91-f38a-5ccc-95f0-68d5ca386095","slug":"referral-for-suspected-gynaecological-cancer","fullItemName":"Scenario: Referral for suspected gynaecological cancer"}]},{"id":"8f87e182-3ee3-55c3-b6ff-ee2773b11083","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"7030c633-3342-56a4-872a-5d01b1950d05","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"3e4a0622-59ba-59f1-a249-25f37835db8f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"598e9e20-db1b-5bd6-bad9-da74dd559795","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d01e7124-01f5-52fc-a22b-2f245daf8632","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e5593853-81b8-58eb-a621-1e437e26ef58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"06edaae5-710d-5a2f-8d9f-e20e29be3d6e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4aae08c9-f011-5561-8ca0-183457de55ec","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"ee6103b8-1f49-5865-acd7-5a9d20d194e6"}},"staticQueryHashes":["3666801979"]}